ALOX5 and triple-A syndrome: Therefore, this study constructed a mouse AAA model by subcutaneously implanting angiotensin II (Ang II) into ApoE−/− mice and induced VSMCs pyroptosis by Ang II to explore how ALOX5 effect AAA progression, providing new targets for the treatment and drug development of AAA.